Introduction {#s1}
============

Avian pathogenic *Escherichia coli* (APEC), a gram-negative, facultative anaerobic bacterium, causes intestinal and extra-intestinal infections, septicemia, and mortality in broiler chickens [@pone.0041645-Barnes1]. The most common infectious bacterial disease in poultry, APEC-induced colibacillosis reduces growth and egg production, thereby causing significant economic losses, as well as potentially contaminating poultry products, which generatess a risk for human health [@pone.0041645-Barnes1], [@pone.0041645-Ron1]. The APEC-O1, O2, O78 serotypes of the O serogroup represent at least half of the total number of isolates [@pone.0041645-DhoMoulin1], [@pone.0041645-Oliveira1], and are responsible for over 80% of human septicemia cases world wide [@pone.0041645-Ron1]. Except for the control of environmental conditions, such as humidity and ventilation, prevention of APEC infection usually relies on antibiotic therapy or vaccine administration. However, vaccines are not fully effective against heterologous APEC strains and there is consumer pressure to reduce the use of antibiotics in food animal production. Elucidating the host resistance mechanisms against APEC infection is a foundational step in developing sustainable strategies to enhance resistance to APEC through development of more effective vaccines and through genetic selection of poultry populations for enhanced innate resistance to APEC.

Until now, the major focus in study of the host:pathogen interaction with APEC has been on the bacteria itself. Some virulence factors or genes responsible for pathogenesis or invasion capacities have been discovered in various APEC strains. With two-dimensional gel electrophoresis, one differentially expressed protein of OmpA was isolated from serum and proposed to be involved in APEC resistance [@pone.0041645-Tyler1]. ExPEC adhesin I has been shown to play a significant role during APEC infection in chickens, as its deletion leads to reduced colonization ability and, moreover, complementation of the adhesin gene restored this ability [@pone.0041645-Anto1]. By microarray investigation and mutational analysis for confirmation, some upregulated APEC genes have been identified in APEC cultured in APEC-treated chicken serum, and these genes are predicted to contribute to APEC virulence [@pone.0041645-Li1]. In addition, some other genes, such as APEC autotransporter adhesin A (*aatA*) and *ibeA* have also been reported to affect APEC infection [@pone.0041645-Dai1], [@pone.0041645-Wang1].

![Schematic of Illumina EST analysis.\
It includes sample preparation, cDNA library construction and Illumina sequencing, data analysis including assemble, blast, GO annotation, gene expression analysis, etc.](pone.0041645.g001){#pone-0041645-g001}

Investigations on the host genomic response is also important, so as to reveal the molecular mechanisms of response to APEC infection. With the sequencing of chicken genome [@pone.0041645-InternationalChickenGenomeSequencing1], the identification of causative genes and markers for APEC susceptibility or resistance at whole genomic or transcriptomic level is practicable and advantageous for genetic selection of poultry with enhanced resistance capabilities. Gene expression profiling by using an avian macrophage microarray revealed 981 differentially expressed chicken ESTs during phagocytosis of *Escherichia coli* (*E. coli*) [@pone.0041645-Bliss1]. A similar study identified 146 common elements modulated by both APEC and *M. synoviae* and exposure to APEC induced higher expression of cytokine genes and genes involved in oxidative burst than *M. synoviae* did [@pone.0041645-Lavric1]. Until now, very few studies at the whole transcriptome level have been reported in response to APEC infection in chicken.

10.1371/journal.pone.0041645.t001

###### Summary of draft reads of three libraries by Illumina deep sequencing.
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  Groups[a](#nt101){ref-type="table-fn"}    PE library size (bp)   Read pairs   Read length (bp)   Total residues (bp)
  ---------------------------------------- ---------------------- ------------ ------------------ ---------------------
  NC                                                200            14,422,935          81             2,336,515,470
  MD                                                200            14,104,324          81             2,284,900,488
  SV                                                200            14,954,692          81             2,422,660,104
  Total                                             200            43,481,951          81             7,044,076,062

NC, MD, and SV are three groups of non-challenged, challenged-mild pathology, and challenged-severe pathology, respectively.

Whole transcriptome shotgun sequencing or RNA-seq is an efficient and reliable technology for transcriptomic analysis so as to reveal genetic architecture, to identify sequence variation, and to quantify gene expression [@pone.0041645-Ozsolak1]. A variety of platforms exist for RNA-Seq, including Illumina Solexa, Roche 454, Life Technology SOLID, and others. Identification of host genetic factors resistance to APEC is of great significance for poultry breeding and production. With use of Illumina deep sequencing of APEC-challenged birds, this study aims to investigate the genetic architecture of the spleen transcriptome, and to discover genes/transcripts and genetic markers for resistance to APEC infection in the chicken.

![Sequence length distribution of contigs assembled from Illumina reads.\
All Illumina reads of non-challenged (NC), challenged-mild pathology (MD) and challenged-severe pathology (SV) were used in assembly analysis which gave rise to 148197 contigs. The horizontal and vertical axes show the size of contigs and log number contigs, respectively.](pone.0041645.g002){#pone-0041645-g002}

Results {#s2}
=======

Illumina Draft Reads {#s2a}
--------------------

In this study, spleens of three males were used to prepare one pooled RNA sample for each group of NC, MD and SV. Three cDNA libraries were then constructed to perform Illumina deep sequencing. The schematic of Illumina deep sequencing and analysis are shown in [Figure 1](#pone-0041645-g001){ref-type="fig"}. We obtained 14,422,935, 14,104,324, 14,954,692 qualified Illumina read pairs for NC, MD, and SV, giving rise to total residues of 2,336,515,470, 2,284,900,488, and 2,422,660,104 bp, respectively. The overall Illumina read pairs and residues for all samples are 43,481,951 and 7,044,076,062 bp, respectively ([Table 1](#pone-0041645-t001){ref-type="table"}).

10.1371/journal.pone.0041645.t002

###### Distribution of contigs and unigenes in chicken genome.
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  Chromosomes    Counts ofcontigs   Counts ofunigenes   Genomesize[a](#nt102){ref-type="table-fn"}
  ------------- ------------------ ------------------- --------------------------------------------
  1                   20,456             14,336                        200,994,015
  2                   14,092             10,142                        154,873,767
  3                   11,719              8,254                        113,657,789
  4                   11,219              7,407                         94,230,402
  5                   9,245               6,303                         62,238,931
  6                   5,098               3,517                         37,400,442
  7                   5,329               3,534                         38,384,769
  8                   5,071               3,344                         30,671,729
  9                   4,427               2,901                         25,554,352
  10                  4,084               2,777                         22,556,432
  11                  3,204               2,243                         21,928,095
  12                  3,446               2,344                         20,536,687
  13                  3,335               2,268                         18,911,934
  14                  4,016               2,598                         15,819,469
  15                  4,105               2,488                         12,968,165
  16                   222                 116                           432,983
  17                  2,996               1,875                         11,182,526
  18                  4,498               1,785                         10,925,261
  19                  3,225               2,066                         9,939,723
  20                  3,204               2,126                         13,986,235
  21                  2,054               1,397                         6,959,642
  22                   834                 539                          3,936,574
  23                  1,885               1,257                         6,042,217
  24                  1,363                932                          6,400,109
  25                   547                 334                          2,031,799
  26                  1,903               1,197                         5,102,438
  27                  1,516                955                          4,841,970
  28                  1,761               1,164                         4,512,026
  Z                   7,304               5,334                         74,602,320
  MT                    13                 10                             16,775
  Total              142,171             95,543                     **1,031,622,801**

Genome size for each chromosome is based on the released chicken whole genome sequence in either NCBI (<ftp://ftp.ncbi.nih.gov/genomes/Gallus_gallus/>) or ENSEMBL database (<ftp://ftp.ensembl.org/pub/release-63/fasta/gallus_gallus/dna/>).

Because some contigs and unigenes have multiple locations in genome, only 134,949 contigs and 91,890 unigenes match with chicken genome.

Assemble and BLAST Analysis {#s2b}
---------------------------

After assembly analysis based on all Illumina reads, we identified 148,197 contigs with total residues of 195,622,566 bp. The average length of all contigs was 1,320 bp, with the smallest sequence of 300 bp and the largest one of 19,212 bp. The sequence length distribution of contigs is indicated in [Figure 2](#pone-0041645-g002){ref-type="fig"} and [Table S1](#pone.0041645.s001){ref-type="supplementary-material"}. Analysis of nucleotide content within all contigs showed that the content of A, T, C, G were 26.45% (51,750,884 nucleotides), 26.52% (51,887,566), 23.83% (46,619,027), and 23.19% (45,365,089), respectively, giving rise to an overall GC content of 47.02% in the chicken whole transcriptome.

![Functional classification of chicken transcriptome.\
(A) GO: Biological process. (B) Cellular component. (C) GO: Molecular function. Each transcript or gene generally has multiple functions.](pone.0041645.g003){#pone-0041645-g003}

![Differentially expressed genes that are unique or shared among three groups of NC, MD and SV.\
NC Vs. MD refers to the comparison between non-challenged (NC) and challenged-mild pathology (MD) groups. NC Vs. SV refers to the comparison between NC and challenged-severe pathology (SV) groups. MD Vs. SV refers to the comparison between MD and SV groups. Numbers in each section of the figure indicate the numbers of differently expressed genes in the indicatedcomparison.](pone.0041645.g004){#pone-0041645-g004}

Further assembly analysis showed that all contigs contributed to 98,461 unigenes. BLAST analysis with the known chicken genome sequence indicated that 134,949 contigs and 91,890 unigenes match the chicken genome. The distributions of contigs and unigenes in chicken chromosomes are described in [Table 2](#pone-0041645-t002){ref-type="table"}.

10.1371/journal.pone.0041645.t003

###### Involvement of differentially expressed genes in predicted pathways by KEGG enrichment analysis.
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  No.                           Pathways                          \#unigenes[1](#nt104){ref-type="table-fn"}      upval       dpval     enrichment
  ----- -------------------------------------------------------- -------------------------------------------- ------------- ---------- ------------
  1                        Metabolic pathways                                     514 (252)                     1.39E−60        1          yes
  2                        Purine metabolism                                      418 (199)                     1.04E−46        1          yes
  3                       Thiamine metabolism                                     359 (181)                     9.06E−47        1          yes
  4                T cell receptor signaling pathway                               105 (38)                     1.80E−06     0.999999      yes
  5              Biosynthesis of secondary metabolites                             98 (53)                      2.15E−17        1          yes
  6                        Lysine degradation                                      75 (42)                      1.48E−13        1          yes
  7                 Drug metabolism - other enzymes                                71 (35)                      6.33E−10        1          yes
  8      Tropane, piperidine and pyridine alkaloid biosynthesis                    56 (30)                      8.95E−10        1          yes
  9           Microbial metabolism in diverse environments                         29 (22)                      2.61E−11        1          yes
  10                   Oxidative phosphorylation                                   28 (21)                      2.32E−11        1          yes
  11                Biosynthesis of phenylpropanoids                               19 (13)                      1.09E−06        1          yes
  12            Metabolism of xenobiotics by cytochrome                             18 (9)                     0.001988018   0.999624      yes
  13                  Drug metabolism - cytochrome                                  18 (9)                     0.001988018   0.999624      yes
  14                    Phenylalanine metabolism                                   17 (14)                      4.38E−08        1          yes
  15                    beta-Alanine metabolism                                     15 (8)                     0.00116723    0.999828      yes
  16                       Methane metabolism                                       13 (9)                      5.11E−05     0.999996      yes
  17                   Glycolysis/Gluconeogenesis                                  12 (10)                      2.44E−06        1          yes
  18                  Phenylpropanoid biosynthesis                                  12 (9)                      2.22E−05     0.999999      yes
  19                      Histidine metabolism                                      6 (6)                      0.00010714       1          yes
  20                      Tyrosine metabolism                                       6 (6)                      0.00010714       1          yes

Refer to the numbers of involved total unigenes and differently expressed unigenes (in bracket).

GO Assignments {#s2c}
--------------

Among 97,491 assembled unigenes, 12,272 were successfully annotated by GO assignments, belonging to one or more of the three categories: biological process, cellular component, and molecular function. Among the annotated unigenes, 11,664 are involved in various biological process categories, including cellular process (9,876 unigenes; 16.33%), metabolic process (7,808; 12.91%), biological regulation (4,969; 8.22%), regulation of biological process (4,391; 7.26%), and others ([Figure 3A](#pone-0041645-g003){ref-type="fig"}). Further, 11,927 unigenes are involved in cellular component categories, including cell part (11,936; 28.38%), cell (11,936; 28.38%), organelle (7,850; 18.66%), organelle part (4,309; 10.25%), macromolecular complex (2,589; 6.16%), membrane-enclosed lumen (1,842; 4.38%), extracellular region (727; 1.73%), extracellular region part (669; 1.59%), and others (200; 0.48%) ([Figure 3B](#pone-0041645-g003){ref-type="fig"}). In addition, 11,963 unigenes are involved in molecular function catgories, including binding (10,141; 49.66%), catalytic activity (5,442; 26.65%), molecular transducer activity (1,271; 6.22%), transporter activity (860; 4.21%), enzyme regulator activity (852; 4.17%), transcription regulator activity (823; 4.03%), nucleic acid binding transcription factor activity (598; 2.93%), structural molecule activity (312; 1.53%), and others (120; 0.59%) ([Figure 3C](#pone-0041645-g003){ref-type="fig"}).

10.1371/journal.pone.0041645.t004

###### Differentially expressed genes involved in the T cell receptor (TCR) signaling pathway.
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  No.    Gene[1](#nt105){ref-type="table-fn"}                                                                                                                                                                                                    Description
  ----- -------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  1                    MAPKSP1                                                 PREDICTED: mitogen-activated protein kinase scaffold protein 1-like isoform 1\#PREDICTED: similar to dual adaptor of phosphotyrosine and 3-phosphoinositides\#PREDICTED: hypothetical protein\#PREDICTED: dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide-like\#PREDICTED: ragulator complex protein LAMTOR3-like
  2                     PTPN13                                                                                                                                                                                        PREDICTED: tyrosine-protein phosphatase non-receptor type 13-like
  3                     PTPRF                                                                                                                                                                                       PREDICTED: receptor-type tyrosine-protein phosphatase F-like, partial
  4                     PPP1CC                                                                                                                                                                            serine/threonine-protein phosphatase PP1-gamma catalytic subunit\#mCG129661, isoform CRA_c
  5                 BTAF1; Dusp11                                                                                                                                             PREDICTED: similar to Dual specificity phosphatase 11 (RNA/RNP complex 1-interacting)\#PREDICTED: TATA-binding protein-associated factor 172-like
  6                  PP2C-epsilon                                                                                                                                                                                            PREDICTED: similar to protein phosphatase 2C epsilon
  7                     PTPN23                                                                                                                                                                             LOC100170608 protein\#PREDICTED: tyrosine-protein phosphatase non-receptor type 23-like
  8                     PTPN14                                                                                                    PREDICTED: similar to protein tyrosine phosphatase, non-receptor type 14 isoform 2\#protein tyrosine phosphatase, non-receptor type 14, isoform CRA_c\#PREDICTED: similar to protein tyrosine phosphatase, non-receptor type 14 isoform 1
  9                      SBF1                                                                                                                                                                                  PREDICTED: similar to tyrosine kinase\#myotubularin-related protein 5 isoform 1
  10                    PTPN11                                                                                                                                                                                        PREDICTED: tyrosine-protein phosphatase non-receptor type 11-like
  11                   KIAA0371                                                                                                                                                                                 PREDICTED: similar to Cysteine rich protein 2\#PREDICTED: similar to KIAA0371
  12                     EYA3                                                                                                                                                                                PREDICTED: eyes absent homolog 3-like isoform 2\#PREDICTED: similar to eyes absent 3
  13                    CD148                                                                                                                                                                                                   receptor-type tyrosine-protein phosphatase eta
  14                    PTPRQ                                                                                                                                                                                               PREDICTED: phosphotidylinositol phosphatase PTPRQ-like
  15                 CD45; PTPRC                                                                                                                                                                                                 receptor-type tyrosine-protein phosphatase C
  16                  p70; STS1                                                                                                                                                                                                     PREDICTED: similar to KIAA1959 protein
  17                     N/A                                                                                                                                                                                                           PREDICTED: hypothetical protein
  18                    Dusp22                                                                                                                                                                                                        PREDICTED: similar to RP23-217J3.1
  19                    Ptprr                                                                                                                                                                                            PREDICTED: receptor-type tyrosine-protein phosphatase R-like
  20                   Ppp2r2a                  serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B alpha isoform\#hypothetical protein PANDA_002366\#PREDICTED: serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B delta isoform-like\#PREDICTED: alpha isoform of regulatory subunit B55, protein phosphatase 2 isoform 1\#unnamed protein product\#PREDICTED: protein phosphatase PP2A 55 kDa regulatory subunit isoform 1
  21                    PPM1A                                                                                                                                                 PREDICTED: protein phosphatase 1A (formerly 2C), magnesium-dependent, alpha isoform\#PREDICTED: similar to protein phosphatase 2C alpha; PP2Calpha
  22                    Dusp11                                                                                                                                                 PREDICTED: similar to Dual specificity phosphatase 11 (RNA/RNP complex 1-interacting)\#PREDICTED: RNA/RNP complex-1-interacting phosphatase-like
  23                    PTPRQ                                                                                                                                                                                               PREDICTED: phosphotidylinositol phosphatase PTPRQ-like
  24                    PTPN6                                                                                                                                                                                                  tyrosine-protein phosphatase non-receptor type 6
  25                 PTPN1; PTP1B                                                                                          tyrosine-protein phosphatase non-receptor type 1\#PREDICTED: similar to PDE4DIP protein\#protein tyrosine phosphatase\#PREDICTED: similar to phosphodiesterase 4D interacting protein\#PREDICTED: tyrosine-protein phosphatase non-receptor type 1-like
  26                    SSH-2                                                                                                                                                                            PREDICTED: similar to slingshot-2L\#PREDICTED: protein phosphatase Slingshot homolog 2-like
  27                    PTPN22                                                                                                                                          PREDICTED: similar to Tyrosine-protein phosphatase non-receptor type 22 (Hematopoietic cell protein-tyrosine phosphatase 70Z-PEP) (Lymphoid phosphatase) (LyP)
  28                     LCK                                                                                                                                                      LCK_CHICKRecName: Full = Proto-oncogene tyrosine-protein kinase LCK; AltName: Full = Protein-tyrosine kinase C-TKL; AltName: Full = p56tk1
  29                   CTDNEP1                                                                                                                                                                                                        CTD nuclear envelope phosphatase 1
  30                    Ppm1k                                                                                                                                           PREDICTED: similar to Protein phosphatase 1K (PP2C domain containing)\#Hyperion protein, 419 kD isoform\#PREDICTED: protein phosphatase 1K, mitochondrial-like
  31                    Ppm1f                                                                                                                                                                                       PREDICTED: similar to Protein phosphatase 1F (PP2C domain containing)
  32                 PTPN5; Step                                                                                                                                                                                       PREDICTED: tyrosine-protein phosphatase non-receptor type 5-like
  33                  RAD9A;RAD9                                                                                                                                                                     cell cycle checkpoint control protein RAD9A\#putative protein phosphatase 1 catalytic subunit alpha
  34                 PTPRB; PTPB                                                                                                                                                                                     PREDICTED: similar to Protein tyrosine phosphatase, receptor type, B
  35                    PTPN21                                                                                                                                                                                        PREDICTED: tyrosine-protein phosphatase non-receptor type 21-like
  36                    MTMR8                                                                                                                                                                                                           myotubularin-related protein 8
  37                     SSH1                                                                                                                                                                                               PREDICTED: similar to Slingshot homolog 1 (Drosophila)
  38                     PIX1                                                                                                                                                                                                       PREDICTED: similar to partner of PIX 1

Genes are named based on NCBI gene database (<http://www.ncbi.nlm.nih.gov/gene/>). N/A means not available.

10.1371/journal.pone.0041645.t005

###### Comparison of gene expression that differs significantly among NC, MD and SV for CD148, CD45 and LCK.

![](pone.0041645.t005){#pone-0041645-t005-5}

  Gene     Expression value[1](#nt106){ref-type="table-fn"}   NC vs. MD   NC vs. SV   MD V = vs. SV                                            
  ------- -------------------------------------------------- ----------- ----------- --------------- ---------- --------- ---------- --------- ----------
  CD148                          955                             991        1191         −0.2113       0.0128    −0.4345   1.45E−10   −0.2232    0.0091
  CD45                          19572                           17645       17329        −0.0084       0.7551    0.0597    0.000912   0.0681     0.0006
  LCK                            1465                           1035         837         0.3434       1.63E-07   0.6917    1.67E−27   0.3484    1.76E-05

The expression value is based on the obtained reads within the specific gene in the three groups of \[non-challenged (NC), challenged-mild pathology (MD), and challenged-severe pathology (SV)\].

Refers to normalized fold changes.

The q-value was calculated according to Benjamini et al. (1995) [@pone.0041645-Benjamini1].

![Comparison of CD148, CD45 and LCK expression among NC, MD and SV.\
(A) CD148. (B) CD45. (C) LCK. NC, MD and SV stand for the groups of non-challenged, challenged-mild pathology, and challenged-severe pathology, respectively. The normalized expression value of NC is set as 1, by which the value of MD and SV are determined. \*, \*\* and \*\*\* represent q-value significance at the level of 0.05, 0.01 and 0.001, respectively.](pone.0041645.g005){#pone-0041645-g005}

Differentially Expressed Genes {#s2d}
------------------------------

Comparison of gene expression showed that a total of 13,650 unigenes were differentially expressed between any two-way comparison of the groups of NC, MD and SV (fold changes ≥2 or ≤−2; q value \<0.01), including 6,844 significantly expressed isogenes between NC and MD (NC Vs. MD), 7,764 between NC and SV (NC Vs. SV), and 2,320 between MD and SV (MD Vs. SV). Moreover, 1,930 unigenes were significantly differentially expressed in both NC Vs. MD and NC Vs. SV, and 548 in NC Vs. MD and MD Vs. SV, as well as 806 in NC Vs. SV and MD Vs. SV. Only 6 unigenes were significantly differentially expressed in all of NC Vs. MD, NC Vs. SV, and MD Vs. SV. Numbers of all differentially expressed genes among the three groups of NC, MD and SV are illustrated in [Figure 4](#pone-0041645-g004){ref-type="fig"}. In addition, there are 531, 115 and 134 unigenes that are uniquely expressed in the group of NC, MD, and SV, respectively.

Metabolic Pathways by KEGG Analysis {#s2e}
-----------------------------------

KEGG enrichment analysis showed that the differentially expressed genes were involved in twenty predicted pathways at a significant level. The pathways and involved unigene numbers are metabolic pathways (514 unigenes and 252 differently expressed unigenes), purine metabolism (418; 199), thiamine metabolism (359; 181), T cell receptor signaling pathway (105; 38), biosynthesis of secondary metabolites (98; 53), lysine degradation (75; 42), drug metabolism-other enzymes (71; 35), tropane, piperidine and pyridine alkaloid biosynthesis (56; 30), microbial metabolism in diverse environments (29; 22), oxidative phosphorylation (28; 21), biosynthesis of phenylpropanoids (19; 13), metabolism of xenobiotics by cytochrome (18; 9), drug metabolism-cytochrome (18; 9), phenylalanine metabolism (17; 14), beta-alanine metabolism (15; 8), methane metabolism (13; 9), glycolysis/gluconeogenesis (12; 10), phenylpropanoid biosynthesis (12; 9), histidine metabolism (6; 6), and tyrosine metabolism (6; 6). All pathways and related information are described in [Table 3](#pone-0041645-t003){ref-type="table"}.

A total of 38 differentially expressed genes are involved in the T cell receptor (TCR) signaling pathway, which has important functions in animal immunity ([Table 4](#pone-0041645-t004){ref-type="table"}). Three crucial genes in this pathway, CD148, CD45, and LCK, exhibited significantly different expression among NC, MD and SV groups ([Table 5](#pone-0041645-t005){ref-type="table"}). The CD148 was significantly up-regulated in SV (P\<0.001) and MD (P\<0.05) compared with NC ([Figure 5A](#pone-0041645-g005){ref-type="fig"}); in contrast, LCK was significantly lower in SV (P\<0.001) and MD (P\<0.001) compared with NC ([Figure 5C](#pone-0041645-g005){ref-type="fig"}). The CD45 gene, was expressed at a significantly lower level in SV compared with NC (P\<0.001) and with MD (P\<0.001), but was not significantly different between NC and MD (P\>0.05) ([Figure 5B](#pone-0041645-g005){ref-type="fig"}).

Discussion {#s3}
==========

Assembly, Blast and GO Analysis {#s3a}
-------------------------------

The high-throughput sequence data obtained by Illumina deep sequencing contributes to the understanding of the genetic architecture of chicken transcriptome. In this study, we pooled RNA from multiple individuals to generate one sample, and subsequently performed Illumina deep sequencing. This pooling strategy was widely used in some similar studies [@pone.0041645-Colaiacovo1], [@pone.0041645-Xie1]. As a result, we generated 148,197 contigs for 195.6 Mb residues of chicken spleen transcriptome based on 43,481,951 Illumina read pairs. Considering all contigs, the overall GC content of the transcriptome was calculated to be 47.02%, which is very close to that reported for genome-wide exons (i.e. 47.00% for GGA4q), but much higher than that of genome-wide introns (i.e. 40.00% for GGA4q) [@pone.0041645-InternationalChickenGenomeSequencing1]. We obtained a total of 98,461 unigenes by further assembly analysis, which was more than all predicted genes (20,000--23,000) in chicken genome [@pone.0041645-InternationalChickenGenomeSequencing1]. We compared our unigenes with NCBI unigene database using blastn, and found that 35,056 unigenes of this study have high similarity with NCBI unigenes (19,218) using 95% identity cutoff. Compared with our unigenes, 1,103 of 19,218 NCBI unigenes are covered by 100% in length, and moreover, 4,326, 2,151 and 2,373 unigenes show the coverage of 90--99%, 80--89%, and 70--79%, respectively. Some unigenes of this study represent for the same NCBI unigene probably because some genes show low expression level in spleen and our Illumina sequences are less deep enough to generate the complete transcript by assemble analysis. Meanwhile, some unigenes of this study are longer than corresponding unigene in NCBI, i.e. 3,661 unigenes were longer than NCBI corresponding unigenes using a cutoff (less than 90% coverage for our unigenes and more than 90% coverage for NCBI unigenes). In addition, there are 7,276 unigenes which couldn't be mapped to chicken genome. These unmapped unigenes still belong to chicken transcriptome, and some if not all of them might be ncRNA which need to be studied in future. Alternative splicing is also very common in chicken genome, as it was previously estimated that 40−60% of all genes and 74% of multiexon genes are alternatively spliced in the human genome [@pone.0041645-Kim1]. GO annotation showed that some unigenes were involved in the three categories of biological process (11,664 unigenes), cellular component (11,927), and molecular function (11,963).

The chicken whole genome was sequenced in 2004 [@pone.0041645-InternationalChickenGenomeSequencing1], but no major update has been published since then. Recently, the genomes of two other avian species, i.e. turkey and zebra finch, were sequenced [@pone.0041645-Dalloul1], [@pone.0041645-Warren1]. The known chicken genome is 1,063 Mb in total length, of which 933 Mb were localized in 29 autosomes (GGA1-28 and 32) and sex chromosomes (Z and W), and the remaining residues were unlocalized [@pone.0041645-InternationalChickenGenomeSequencing1], [@pone.0041645-Wallis1]. In the current study, blast analysis with the chicken genome showed that most contigs and unigenes mapped to GGA1-5 and the Z chromosome, corresponding to the fact that these macrochromosomes contain a major part of the chicken genome [@pone.0041645-Wallis1]. It is logical that no contig or unigene was found for the known GGA32, because only 1,028 bp of sequences are available in this chromosome (<ftp://ftp.ncbi.nih.gov/genomes/Gallus_gallus/>).

Even though the chicken transcriptome of various tissues has been investigated by cDNA microarray or gene chip [@pone.0041645-Li1], [@pone.0041645-Bliss1], [@pone.0041645-Lavric1], this technology fails to detect sequence variation and to recognize new genes or transcripts. With emergence of second generation sequencing, RNA-seq is a more powerful approach for transcriptome analysis [@pone.0041645-Ozsolak1]; however, such investigations in chickens and other birds are very limited. Recently, a total of 856,675 Roche 454 reads were obtained in crows and further expression analysis indicated a general pattern of ineffective dosage compensation in that species [@pone.0041645-Wolf1], [@pone.0041645-Wolf2]. The results of the current study as well as 148,197 Illumina reads are useful resource for further investigation on chicken transcriptome.

Differently Expressed Genes for APEC {#s3b}
------------------------------------

Comparison of gene expression among the different treatment groups in the current experiment is helpful for identification of candidate genes underlying response and resistance to APEC infection in chicken. Many fewer differentially expressed unigenes were found in the MD Vs. SV contrast (2,320) compared with that of NC Vs. MD (6,844) and NC Vs. SV (7,764), revealing that there is greater difference between infected and non-infected states than between mild and severe infections. Among the differently expressed genes, there are 531, 115 and 134 unigenes that specifically express in NC, MD, and SV groups, respectively. Our previous study with cDNA microarray technology revealed 1,101 significantly expressed genes between SV and NC [@pone.0041645-Sandford1]. Because RNA-Seq can recognize new unigenes or unique isoforms present in chicken transcriptome, it should be more powerful in expression analysis. Further, KEGG prediction and GO analysis showed that these differently expressed genes were involved in a couple of major pathways. It is notable that 38 and 22 unigenes are contained in the two predicted pathways of TCR signaling pathway and microbial metabolism in diverse environments, respectively, suggesting that these unigenes are candidate genes for APEC infection in chicken.

The TCR signaling in response to antigen recognition can induce integrin to facilitate T-cell activation and thus the TCR signaling pathway has a central role in the adaptive immune response [@pone.0041645-Burbach1], [@pone.0041645-Huse1]. Within the TCR signaling pathway, CD148, CD45 and LCK are crucial genes that regulate the signal transduction throughout the entire network [@pone.0041645-Lin1], [@pone.0041645-Hermiston1]. It is notable that CD45 and CD148 are specifically required for *L. pneumophila* phagocytosis and effector translocation [@pone.0041645-Charpentier1], suggesting that they are involved in the interaction between host and bacterium. It has been proposed that CD45 is alone sufficient for TCR triggering [@pone.0041645-Choudhuri1] and, moreover, CD45 deficiency results in a severe combined immunodeficiency phenotype [@pone.0041645-Hermiston1]. In the current study, both CD45 and LCK were significantly downregulated in SV compared to NC and MD (P\<0.001), which supports the critical function of CD45 in the immune response to APEC in chicken. The expression of CD148 was upregulated in SV compared with NC (P\<0.001) and MD (P\<0.01) in this study. The true function of CD148 in the immune system remains unclear and there are contrary opinions regarding whether CD148 is dispensable for normal growth and development [@pone.0041645-Hermiston1]. The identified unigenes in the TCR signaling pathway are candidate genes for APEC infection in chicken, and warrant additional functional confirmation by further investigation.

The cytokine interleukin-1 beta (IL1B) is known as a "master" cytokines and plays a great role on the process of anti-infectious protection. In the pathogenesis of APEC, we found that IL1B expression was significantly up-regulated in both SV and MD compared to NC, and moreover SV showed higher IL1B level than MD. It indicated that IL1B was a key cytokine responsible for the inflammation process caused by APEC infection. A similar result was also found in cow mastitis. Investigation on the global transcription of Mild priming primary mammary epithelial cells (MEC) of cow for 12 h with lipopolysaccharide (LPS) (100 ng/ml) before stimulated with heat inactivated E. coli bacteria showed that, the expression of IL1B was significantly down-regulated to inhibit inflammation [@pone.0041645-Gnther1]. Moreover, it was predicted that IL1B could directly regulate 44 differently expressed genes in the process of LPS priming-mediated modulation of the E. coli-elicited response [@pone.0041645-Gnther1].

Toll-like receptors are important factors for immune response. In this study, TLR4 was significantly up-regulated in MD (2.3 folds) and SV (2.9 folds) compared to NC, which was consensus to the study of TLR4 in human. After co-stimulation the T24 human bladder carcinoma cell with E. coli and lactobacilli, TLR4 were significantly increased in both mRNA and protein level, and inhibition of TLR4 blocked the lactobacilli potentiation of NF-kappaB [@pone.0041645-Karlsson1]. TLR2 were also up regulated in MD (3.0 folds) and SV (3.3 folds) compared to NC. It was reported the TLR2 subfamily were involved in the avian response to C. perfringens challenge [@pone.0041645-Lu1].

Compared to NC, the L-phenylalanine oxidase IL4I1 up-regulated its expression in SV and MD at 20 and 39 folds respectively. Meanwhile, IL4I1 expression in SV was about 2 fold higher than MD. It indicated that IL4I1 facilitates the pathogens of APEC. In human, it was proved that IL4I1 improve tumor growth by inhibiting the CD8(+) antitumor T-cell response [@pone.0041645-Lasoudris1].

Materials and Methods {#s4}
=====================

Ethics Statement {#s4a}
----------------

The APEC challenge experiment and sample collection were approved by the Iowa State University Institutional Animal Care and Use Committee (\# 11-07-6460-G).

APEC Challenge Experiment and Sample Preparation {#s4b}
------------------------------------------------

A total of 240 non-vaccinated commercial male broilers at 4 weeks age were challenged with 0.1 ml APEC O1 (10E8 colony forming units) by the intra-air sac route into the left thoracic airsac. Another 120 non-vaccinated males were non-challenged (NC) but treated with 0.1 ml phosphate buffered saline (PBS). All detailed information on the APEC O1 strain and challenge design and procedures was previously described [@pone.0041645-Sandford1]. Birds were euthanized and necropsy was performed at one day post challenge. Based upon pathological finds a summarized lesion score, ranging from 0 to 7, was determined for each bird. Birds with lesion scores of 0--2 were regarded as mild pathology (resistant phenotype), and those scoring 4--7 as severe pathology (susceptible phenotype). Subsequently, spleens from three groups \[non-challenged NC, challenged-mild pathology (MD) and challenged-severe pathology (SV)\] were subjected to Illumina deep sequencing to investigate the dynamic responses of chicken transcriptome. The recorded lesions (mean ± standard deviation) for NC, MD, and SV groups were 0.00±0.00, 0.50±0.58, and 5.25±1.26, respectively.

RNA Isolation, cDNA Library Construction and Illumina Deep Sequencing {#s4c}
---------------------------------------------------------------------

For each group, three spleens were randomly chosen and shipped on RNAlater (Applied Biosystems) to Shanghai Majorbio Bio-pharm Biotechnology Co., Ltd. (Shanghai, China), where total RNA was isolated from each spleen by trizol (Invitrogen, CA, USA). Then, samples of three individuals were pooled within each group in equal amounts to generate one mixed sample per group by RNA pooling. These three mixed RNA samples were subsequently used in cDNA library construction and Illumina deep sequencing.

Three cDNA libraries were prepared using the TruseqTM RNA sample prep Kit (Illumina, San Diego, CA USA) following the manufacturer's instructions. First, magnetic beads containing poly-T molecules were used to purify mRNA from 10 µg of total RNA. Second, the three samples were chemically fragmented and reverse transcribed into cDNA. Third, end repair and A-base tailing was performed and then Illumina adapters were ligated to the cDNA fragments.

After a gel size fractionation step to extract fragments of 300 bp, 29 µL of the purified samples were amplified by 15-cycle PCR. Amplified products were validated and quantified using an Agilent 2100 bioanalyzer and the DNA 1000 Nano Chip Kit (Agilent, Technologies, Santa Clara, CA, USA). Libraries were loaded onto the channels of the flow cell at 8 pM concentration. Sequencing was performed on the Genome Analyzer IIx (Illumina, San Diego, CA, USA) by running 81+7+81 cycles using Illumina's cBot Paired End Cluster Plate Kit and 36 Cycle Sequencing Kit according to the manufacturer's instructions.

Bioinformatic Analysis {#s4d}
----------------------

### Reads trimming and assembly {#s4d1}

For each of the sequencing reads, low quality bases (Sanger base quality \<20) of 3′ ends were first trimmed using in-house perl scripts and then the sequencing adapters were trimmed using fastx_toolkit software (<http://hannonlab.cshl.edu/fastx_toolkit/>). All Illumina reads of three samples (NC, MD and SV) were assembled by Trinity software using default parameters [@pone.0041645-Grabherr1].

Transcriptome Annotation {#s4e}
------------------------

The isogenes were compared with the protein nonredundant database using BlastX with E values less than 1.0×10^−5^ (E values less than 1.0×10^−5^ were considered as significant) [@pone.0041645-Altschul1]. Gene ontology (GO) terms were extracted from the best hits obtained from the BlastX against the nr database (E value ≤1.0×10^−6^) using blast2go, and then sorted for the GO categories using in-house perl scripts [@pone.0041645-Ashburner1]. Metabolic pathway analysis was performed using the Kyoto Encyclopedia of Genes and Genomes (KEGG).

Expression Analysis {#s4f}
-------------------

Reads from each samples were mapped to isogenes using bowtie software respectively using corresponding parameters for pair ends reads and single reads [@pone.0041645-Langmead1]. The expression of each gene was calculated using the numbers of reads mapping to its isogenes. For calculating gene expression correctly, reads which aligned to different isogenes of the same gene were only counted once. Reads which have best alignments to more than one gene were not counted. Both reads from a read pair were removed if one read aligned to one gene and the other aligned to another gene. The differentially expressed genes were analyzed using the R package DEGseq and the Benjamini q-value was calculated [@pone.0041645-Wang2], [@pone.0041645-Benjamini1]. Gene Ontology and KEGG pathway enrichment analysis was performed by using the GOseq package, which took gene length bias into account, using a 0.05 cutoff for the false discovery rate [@pone.0041645-Young1].

The according to et al. (1995).

Supporting Information {#s5}
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**Sequence length distribution of 148,197 assembled contigs.** Frequencies refer to the percentage of the contigs with each different sequence length.
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Click here for additional data file.
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